Across TCGA pan-cancer cohorts, VPS26CP1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated VPS26CP1 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher VPS26CP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated VPS26CP1 expression acts as an unfavorable survival marker, although some lineages such as PAAD show a favorable association.
THCA, KICH, and BLCA are the cancer types where VPS26CP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.